Humacyte, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
HUMA Nasdaq 2836 www.humacyte.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Humacyte, Inc.

Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2026 6:20 am
Humacyte, Inc. (HUMA) Rises As Market Takes a Dip: Key Facts - Aug 5th, 2026 4:00 pm
Amgen (AMGN) Q2 Earnings and Revenues Surpass Estimates - Aug 4th, 2026 3:15 pm
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Jul 28th, 2026 4:00 pm
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting - Jul 27th, 2026 6:00 am
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - Jul 21st, 2026 4:00 pm
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights - Jul 20th, 2026 4:15 pm
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access - Jul 14th, 2026 6:00 am
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - Jun 30th, 2026 4:00 pm
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data - Jun 27th, 2026 8:06 am
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market - Jun 25th, 2026 4:15 pm
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet - Jun 19th, 2026 7:30 am
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know - Jun 16th, 2026 4:00 pm
Humacyte, Inc. (HUMA) Upgraded to Buy: Here's What You Should Know - Jun 15th, 2026 10:00 am
Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting - Jun 15th, 2026 6:00 am
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock - Jun 10th, 2026 7:08 pm
Humacyte, Inc. Announces Proposed Public Offering of Common Stock - Jun 10th, 2026 6:55 pm
HUMA Stock Plunges After-Hours On Proposed Share Offering Even As Dialysis Data Impresses - Jun 10th, 2026 4:48 pm
Humacyte Says ATEV Met Late-Stage Study Endpoint in Interim Analysis, Launches Public Offering; Shares Fall - Jun 10th, 2026 2:51 pm
Humacyte ATEV Met Superiority Primary Endpoint Compared to Standard of Care AV Fistula in Interim Analysis of V012 Phase 3 Study in Female Dialysis Access Patients - Jun 10th, 2026 2:01 pm